Syngenta introduces new Talon Ultrablok rodenticide

Syngenta Professional Pest Management (PPM) is unveiling new Talon Ultrablok rodenticide. Formulated with the latest technology in rodent palatability, Talon Ultrablok can provide pest management professionals (PMPs) with a tool to effectively control rodents and combat resistance, Syngenta reports.

“The new Talon Ultrablok formula is based on innovations in food science,” explained ElRay Roper, senior technical representative for Syngenta PPM in North America. “This formula ensures maximum attractiveness and palatability to rodents.”

Talon Ultrablok contains brodifacoum, as well as unique ingredients that have been shown to improve acceptance of the bait, the manufacturer reports. Rodents are only required to eat a small dosage of the active ingredient, which helps control rodents in a single feeding, including warfarin-resistant rodents, Syngenta says.

Talon Ultrablok also features innovative packaging that was specifically designed to be convenient for PMPs. It is available in an easy-to-carry 16 pound case with side and top handles, which contains two fully labelled 8 pound bags of product. Each 8 pound bag is dual-walled and can be resealed, providing long-lasting bait freshness. Each bag can also be placed individually in service vehicles for added convenience.

Syngenta’s rodenticide portfolio also includes Talon-G and Weatherblok XT rodenticide. “We understand PMPs need rodent control they can rely on, for their businesses and customers,” said John Dombrosky, head of marketing for Syngenta PPM, Americas. “PMPs can be confident that the advanced formulation of Talon Ultrablok will get the job right the first time and help them provide a rodent-free environment for their customers.”

For more information
T: +1 1-866-SYNGENT(A) (796-4368)

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.